News and Trends 31 Jan 2023
Abbisko Therapeutics receives breakthrough therapy designation for CSF-1R inhibitor
Abbisko Therapeutics Co., Ltd. has announced that its CSF-1R inhibitor Pimicotinib has been granted the breakthrough therapy designation from the…